Neoadjuvant Immunotherapy Shows Promise for Resectable CSCC

Some patients develop more advanced cancer that requires surgery, often on exposed surfaces like the scalp, face, or neck.

Related Keywords

Germany ,Australia ,Houston ,Texas ,United States ,Neil Gross ,University Of Texas Md Anderson Cancer Center ,Drug Administration ,European Society For Medical Oncology ,Cancer Center ,European Society ,Medical Oncology ,New England Journal ,Biologic Therapy ,Neoadjuvant ,Surgery ,Clinical Research ,Clinical Trials ,Linical Studies ,Immunotherapy ,Presection ,Advanced Cancer ,Europe ,European ,Palliative Care ,Skin Cancer ,Alignant Skin Neoplasm ,Squamous Cell Carcinoma Of The Skin ,